Table: Apex Biotechnology May Rev NT$145.7M Vs NT$177.8M

About this update from Apex Biotechnology Corp.

Apex Biotechnology Corp. - Taiwan Figures in New Taiwan dollars. 2026 2025 Revenue NT$145,664,000 NT$177,828,000 Jan-May Revenue NT$816,424,000 NT$923,843,000 Source: Taiwan Stock Exchange This content was automatically published based on data and/or text from the original source. For feedback, write to [email protected].

View stock analysis, news, and events for Apex Biotechnology Corp.